Malik Dania G, Smith Mathew V, Swenson Gabriel M, Grady Robert E, Diehn Felix E, Middlebrooks Erik H, Ross Jeffrey S, Rath Tanya J
From the Department of Radiology (D.G.M., M.V.S., G.M.S., R.E.G., J.S.R., T.J.R.), Mayo Clinic, Phoenix, Arizona
From the Department of Radiology (D.G.M., M.V.S., G.M.S., R.E.G., J.S.R., T.J.R.), Mayo Clinic, Phoenix, Arizona.
AJNR Am J Neuroradiol. 2025 Jul 1;46(7):1478-1485. doi: 10.3174/ajnr.A8630.
Studies show a modest yield for image-guided biopsy of suspected vertebral osteomyelitis-discitis. Many studies evaluate factors to improve diagnostic yield, and few studies assess how biopsy results impact clinical management. We aim to evaluate the impact of biopsy results on clinical management in suspected vertebral osteomyelitis-discitis.
We performed a retrospective study of patients who underwent image-guided biopsy for suspected vertebral osteomyelitis-discitis. Data collected included risk factors, imaging findings, laboratory values, antibiotics, biopsy procedure details, microbiology and pathology results, and clinical course. Factors assessed for management change included whether biopsy results affected antibiotic type or course, decision to start or stop antibiotics, surgical decisions, or if an alternate diagnosis was determined.
Three hundred ten biopsies were included. Biopsy yield with true-positive culture results was 34% (104/310) and similar for patients on antibiotics (36%, 34/94) and off antibiotics (32%, 66/204). Yield was greater when disc was sampled (36%, 82/228) versus bone only (8%, 2/24) and with aspiration of disc and/or bone (42%, 39/92) versus core only (29%, 56/193). With positive blood cultures before biopsy, biopsy yield was 50% (22/44) with concordance and discordance rates of 75% (18/24) and 17% (4/24), respectively, and 8% (2/24) of positive biopsy results deemed contaminants. Management was affected in 36% (113/310) of all biopsies and in 78% (81/104) of biopsies with a positive culture result. No management change occurred in 57% (177/310) of biopsies. Management change was unclear in 6% (20/310). Biopsy results changed antibiotics in 27% (85/310). Management change occurred in 23% (10/44) of cases with prior positive blood culture compared with 41% (93/233) without a prior culture source ( = .024). Negative culture results influenced management in 16% (32/194).
Image-guided biopsy for vertebral osteomyelitis-discitis has a meaningful impact on management despite modest yield. Greatest management impact is seen with positive culture results, no prior culture source, and patients not on antibiotics at the time of biopsy. Biopsy culture yield is not affected by preceding antibiotics, and yield is greater with disc sampling and aspiration.
研究表明,影像引导下对疑似椎体骨髓炎-椎间盘炎进行活检的阳性率适中。许多研究评估了提高诊断阳性率的因素,而很少有研究评估活检结果如何影响临床管理。我们旨在评估活检结果对疑似椎体骨髓炎-椎间盘炎临床管理的影响。
我们对因疑似椎体骨髓炎-椎间盘炎接受影像引导下活检的患者进行了一项回顾性研究。收集的数据包括危险因素、影像学表现、实验室检查值、抗生素使用情况、活检操作细节、微生物学和病理学结果以及临床病程。评估对管理产生改变的因素包括活检结果是否影响抗生素类型或疗程、开始或停止使用抗生素的决定、手术决策,或者是否确定了其他诊断。
共纳入310例活检病例。培养结果为真阳性的活检阳性率为34%(104/310),使用抗生素的患者(36%,34/94)与未使用抗生素的患者(32%,66/204)相似。对椎间盘进行采样时的阳性率(36%,82/228)高于仅对骨进行采样(8%,2/24),对椎间盘和/或骨进行穿刺抽吸时的阳性率(42%,39/92)高于仅取组织芯时(29%,56/193)。活检前血培养阳性的患者,活检阳性率为50%(22/44),符合率和不符合率分别为75%(18/24)和17%(4/24),8%(2/24)的活检阳性结果被视为污染菌。所有活检中有36%(113/310)的病例管理受到影响,培养结果为阳性的活检中有78%(81/104)的病例管理受到影响。57%(177/310)的活检病例管理未发生改变。6%(20/310)的病例管理改变情况不明确。活检结果使27%(85/310)的患者抗生素使用发生改变。与没有先前培养来源的患者相比,先前血培养阳性的病例中有23%(10/44)发生管理改变,而没有先前培养来源的患者中有41%(93/233)发生管理改变(P = 0.024)。阴性培养结果对16%(32/194)的病例管理产生影响。
尽管影像引导下对椎体骨髓炎-椎间盘炎进行活检的阳性率适中,但对管理仍有显著影响。培养结果为阳性、没有先前培养来源以及活检时未使用抗生素的患者,管理受到的影响最大。活检培养阳性率不受先前使用抗生素的影响,对椎间盘进行采样和穿刺抽吸时阳性率更高。